Download PDF
Thromb Haemost 1999; 82(02): 806-809
DOI: 10.1055/s-0037-1615915
Research Article
Schattauer GmbH

Cell Signaling in Injured Rat Arteries

Hiroyuki Koyama
1   University of Washington, Seattle, Washington, USA
,
N. Eric Olson
1   University of Washington, Seattle, Washington, USA
,
Michael A. Reidy
1   University of Washington, Seattle, Washington, USA
› Author Affiliations
Further Information

Publication History

Publication Date:
09 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Jawien AD, Bowen-Pope DF, Lindner V, Schwartz SM, Clowes AW. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J.Clin.Invest 1992; 89: 507-511.
    PubMedGoogle Scholar
  • 2 Clowes AW, Clowes MM, Reidy MA. Kinetics of cellular proliferation after arterial injury. III. Endothelial and smooth muscle growth in chronically denuded vessels. Lab Invest 1986; 54: 295-303.
    PubMedGoogle Scholar
  • 3 Koyama H, Olson NE, Dastvan FF, Reidy MA. Smooth muscle cell replication-activation of signaling pathways following in vivo injury. Circ.Res 1998; 82: 713-721.
    PubMedGoogle Scholar
  • 4 Lindner V, Olson NE, Clowes AW, Reidy MA. Inhibition of smooth muscle cell proliferation in injured rat arteries. Interaction of heparin with basic fibroblast growth factor. J Clin Invest 1992; 90: 2044-2049.
    CrossrefPubMedGoogle Scholar
  • 5 Lindner V, Reidy MA. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci USA 1991; 88: 3739-3743.
    CrossrefPubMedGoogle Scholar
  • 6 Reidy MA, Lindner V. Basic FGF and growth of arterial cells. Ann NY Acad Sci 1991; 638: 290-299.
    CrossrefPubMedGoogle Scholar
  • 7 Schwartz SM, Reidy MA, O’Brien ERM. Assessment of factors important in atherosclerotic occlusion and restenosis. Thromb Haemost 1995; 74: 541-551.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Downward J. Cell cycle: routine role for Ras. Curr Biol. 1997; 7: R258-260.
    CrossrefPubMedGoogle Scholar
  • 9 Widmann C, Gibson S, Jarpe MB, Johnson GL. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 1999; 79: 143-80.
    CrossrefPubMedGoogle Scholar
  • 10 Vanhaesebroeck B, Stein RC, Waterfield MD. The study of phosphoinositide 3-kinase function. Cancer Surv. 1996; 27: 249-270.
    PubMedGoogle Scholar
  • 11 Franke TF, Yang SI, Chan TO, Datta K, Kazlauskas A, Morrison DK, Kaplan DR, Tsichlis PN. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 1995; 81: 727-736.
    CrossrefPubMedGoogle Scholar
  • 12 Klippel A, Kavanaugh WM, Pot D, Williams LT. A specific product of phosphatidylinositol 3-kinase directly activates the protein kinase Akt through its pleckstrin homology domain. Mol Cell Biol 1997; 17: 338-344.
    CrossrefPubMedGoogle Scholar
  • 13 Marte BM, Downward J. PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond. TrendsBiochemSci. 1997; 22: 355-358.
    PubMedGoogle Scholar
  • 14 Koyama H, Reidy MA. Activation of the PI(3) kinase signaling pathway after balloon catheter injury. Circ.Res. 1998; XX-XX.
    PubMedGoogle Scholar
  • 15 Ui M, Okada T, Hazeki K, Hazeki O. Wortmannin as a unique probe for an intracellular signaling protein, phosphoinositide 3-kinase. Trends Biochem Sci 1995; 20: 303-307.
    CrossrefPubMedGoogle Scholar
  • 16 Vlahos CJ, Matter WF, Hui KY, Brown RF. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 1994; 269: 5241-5248.
    PubMedGoogle Scholar
  • 17 Sherr CJ. Mammalian G1 cyclins. Cell 1993; 73: 1059-1065.
    PubMedGoogle Scholar
  • 18 Sherr CJ, Roberts JM. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Development 1995; 9: 1149-1163.
    CrossrefPubMedGoogle Scholar
  • 19 Lavoie JN, L’Allemain G, Brunet A, Muller R, Pouyss’egur J. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J.Biol.Chem 1996; 271: 20608-20616.
    PubMedGoogle Scholar